Literature DB >> 27890796

Temporal profiles of plasma proteome during childhood development.

Chih-Wei Liu1, Lisa Bramer2, Bobbie-Jo Webb-Robertson2, Kathleen Waugh3, Marian J Rewers4, Qibin Zhang5.   

Abstract

Human blood plasma proteome reflects physiological changes associated with a child's development as well as development of disease states. While age-specific normative values are available for proteins routinely measured in clinical practice, there is paucity of comprehensive longitudinal data regarding changes in human plasma proteome during childhood. We applied TMT-10plex isobaric labeling-based quantitative proteomics to longitudinally profile the plasma proteome in 10 healthy children during their development, each with 9 serial time points from 9months to 15years of age. In total, 1828 protein groups were identified at peptide and protein level false discovery rate of 1% and with at least two razor and unique peptides. The longitudinal expression profiles of 1747 protein groups were statistically modeled and their temporal changes were categorized into 7 different patterns. The patterns and relative abundance of proteins obtained by LC-MS were also verified with ELISA. To our knowledge, this study represents the most comprehensive longitudinal profiling of human plasma proteome to date. The temporal profiles of plasma proteome obtained in this study provide a comprehensive resource and reference for biomarker studies in childhood diseases. Biological significance: A pediatric plasma proteome database with longitudinal expression patterns of 1747 proteins from neonate to adolescence was provided to the research community. 970 plasma proteins had age-dependent expression trends, which demonstrated the importance of longitudinal profiling study to identify the potential biomarkers specific to childhood diseases, and the requirement of strictly age-matched clinical samples in a cross-sectional study in pediatric population.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Childhood development; Human plasma proteome; Pediatric proteome; TMT10; Tandem mass tags; Temporal proteome profiling

Mesh:

Substances:

Year:  2016        PMID: 27890796      PMCID: PMC5219852          DOI: 10.1016/j.jprot.2016.11.016

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  43 in total

1.  Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B.

Authors:  Matti Hero; Johanna Tommiska; Kirsi Vaaralahti; Eeva-Maria Laitinen; Ilkka Sipilä; Lea Puhakka; Leo Dunkel; Taneli Raivio
Journal:  Fertil Steril       Date:  2012-03-09       Impact factor: 7.329

Review 2.  On the development of plasma protein biomarkers.

Authors:  Silvia Surinova; Ralph Schiess; Ruth Hüttenhain; Ferdinando Cerciello; Bernd Wollscheid; Ruedi Aebersold
Journal:  J Proteome Res       Date:  2010-12-13       Impact factor: 4.466

Review 3.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

4.  More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS.

Authors:  Annette Michalski; Juergen Cox; Matthias Mann
Journal:  J Proteome Res       Date:  2011-02-28       Impact factor: 4.466

5.  Serum proteomes distinguish children developing type 1 diabetes in a cohort with HLA-conferred susceptibility.

Authors:  Robert Moulder; Santosh D Bhosale; Timo Erkkilä; Essi Laajala; Jussi Salmi; Elizabeth V Nguyen; Henna Kallionpää; Juha Mykkänen; Mari Vähä-Mäkilä; Heikki Hyöty; Riitta Veijola; Jorma Ilonen; Tuula Simell; Jorma Toppari; Mikael Knip; David R Goodlett; Harri Lähdesmäki; Olli Simell; Riitta Lahesmaa
Journal:  Diabetes       Date:  2015-01-23       Impact factor: 9.461

6.  Depletion of abundant plasma proteins and limitations of plasma proteomics.

Authors:  Chengjian Tu; Paul A Rudnick; Misti Y Martinez; Kristin L Cheek; Stephen E Stein; Robbert J C Slebos; Daniel C Liebler
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

Review 7.  Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism.

Authors:  I Zofková
Journal:  Physiol Res       Date:  2003       Impact factor: 1.881

8.  Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.

Authors:  Qibin Zhang; Thomas L Fillmore; Athena A Schepmoes; Therese R W Clauss; Marina A Gritsenko; Patricia W Mueller; Marian Rewers; Mark A Atkinson; Richard D Smith; Thomas O Metz
Journal:  J Exp Med       Date:  2012-12-31       Impact factor: 14.307

9.  Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery.

Authors:  Cong Zhou; Kathryn L Simpson; Lee J Lancashire; Michael J Walker; Martin J Dawson; Richard D Unwin; Agata Rembielak; Patricia Price; Catharine West; Caroline Dive; Anthony D Whetton
Journal:  J Proteome Res       Date:  2012-03-12       Impact factor: 4.466

Review 10.  Isobaric labeling-based relative quantification in shotgun proteomics.

Authors:  Navin Rauniyar; John R Yates
Journal:  J Proteome Res       Date:  2014-11-04       Impact factor: 4.466

View more
  6 in total

1.  Temporal expression profiling of plasma proteins reveals oxidative stress in early stages of Type 1 Diabetes progression.

Authors:  Chih-Wei Liu; Lisa Bramer; Bobbie-Jo Webb-Robertson; Kathleen Waugh; Marian J Rewers; Qibin Zhang
Journal:  J Proteomics       Date:  2017-10-07       Impact factor: 4.044

Review 2.  Immunological biomarkers for the development and progression of type 1 diabetes.

Authors:  Chantal Mathieu; Riitta Lahesmaa; Ezio Bonifacio; Peter Achenbach; Timothy Tree
Journal:  Diabetologia       Date:  2018-09-12       Impact factor: 10.122

3.  Characterization and non-parametric modeling of the developing serum proteome during infancy and early childhood.

Authors:  Niina Lietzén; Lu Cheng; Robert Moulder; Heli Siljander; Essi Laajala; Taina Härkönen; Aleksandr Peet; Aki Vehtari; Vallo Tillmann; Mikael Knip; Harri Lähdesmäki; Riitta Lahesmaa
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

4.  Longitudinal effects of aging on plasma proteins levels in older adults - associations with kidney function and hemoglobin levels.

Authors:  Lars Lind; Johan Sundström; Anders Larsson; Erik Lampa; Johan Ärnlöv; Erik Ingelsson
Journal:  PLoS One       Date:  2019-02-25       Impact factor: 3.240

5.  Diurnal variation of inflammatory plasma proteins involved in pain.

Authors:  Hajer Jasim; Anders Carlsson; Björn Gerdle; Malin Ernberg; Bijar Ghafouri
Journal:  Pain Rep       Date:  2019-08-13

6.  MALDI-TOF Protein Profiling Reflects Changes in Type 1 Diabetes Patients Depending on the Increased Amount of Adipose Tissue, Poor Control of Diabetes and the Presence of Chronic Complications.

Authors:  Agnieszka Zawada; Dariusz Naskręt; Eliza Matuszewska; Zenon Kokot; Marian Grzymisławski; Dorota Zozulińska-Ziółkiewicz; Agnieszka Dobrowolska; Jan Matysiak
Journal:  Int J Environ Res Public Health       Date:  2021-02-25       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.